ReP USP - Resultado da busca

Artigo de periodico
Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis (2019)
Silva, M. G; Shinjo, Sueli Mieko Oba ; Marie, Suely Kazue Nagahashi ; Shinjo, Samuel Katsuyuki
Source: Clinical and experimental rheumatology. Unidade: FM
Subjects: INTERLEUCINAS, MIOSITE, DERMATOPATIAS, ESTUDOS TRANSVERSAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, M. G et al. Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis. Clinical and experimental rheumatology, v. 37, n. 4, p. 656-662, 2019Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/33118. Acesso em: 22 ago. 2024.
APA
Silva, M. G., Shinjo, S. M. O., Marie, S. K. N., & Shinjo, S. K. (2019). Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis. Clinical and experimental rheumatology, 37( 4), 656-662. Recuperado de http://observatorio.fm.usp.br/handle/OPI/33118
NLM
Silva MG, Shinjo SMO, Marie SKN, Shinjo SK. Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis [Internet]. Clinical and experimental rheumatology. 2019 ; 37( 4): 656-662.[citado 2024 ago. 22 ] Available from: http://observatorio.fm.usp.br/handle/OPI/33118
Vancouver
Silva MG, Shinjo SMO, Marie SKN, Shinjo SK. Serum interleukin-17A level is associated with disease activity of adult patients with dermatomyositis and polymyositis [Internet]. Clinical and experimental rheumatology. 2019 ; 37( 4): 656-662.[citado 2024 ago. 22 ] Available from: http://observatorio.fm.usp.br/handle/OPI/33118
Artigo de periodico-carta/editorial
Beyond medicine: Physical exercise should be always considered in patients with systemic autoimmune myopathies (2019)
Oliveira, Diego Sales de; Souza, Jean Marcos de; Shinjo, Samuel Katsuyuki
Source: Autoimmunity reviews. Unidade: FM
Subjects: EXERCÍCIO FÍSICO, MIOSITE, DOENÇAS AUTOIMUNES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Diego Sales de e SOUZA, Jean Marcos de e SHINJO, Samuel Katsuyuki. Beyond medicine: Physical exercise should be always considered in patients with systemic autoimmune myopathies. Autoimmunity reviews. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.autrev.2018.11.003. Acesso em: 22 ago. 2024. , 2019
APA
Oliveira, D. S. de, Souza, J. M. de, & Shinjo, S. K. (2019). Beyond medicine: Physical exercise should be always considered in patients with systemic autoimmune myopathies. Autoimmunity reviews. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.autrev.2018.11.003
NLM
Oliveira DS de, Souza JM de, Shinjo SK. Beyond medicine: Physical exercise should be always considered in patients with systemic autoimmune myopathies [Internet]. Autoimmunity reviews. 2019 ; 18( 3): 315-316.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1016/j.autrev.2018.11.003
Vancouver
Oliveira DS de, Souza JM de, Shinjo SK. Beyond medicine: Physical exercise should be always considered in patients with systemic autoimmune myopathies [Internet]. Autoimmunity reviews. 2019 ; 18( 3): 315-316.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1016/j.autrev.2018.11.003
Artigo de periodico
Comparison between treatment naive juvenile and adult dermatomyositis muscle biopsies: difference of inflammatory cells phenotyping (2018)
Shinjo, Samuel Katsuyuki; Sallum, Adriana Maluf Elias; Shinjo, Sueli Mieko Oba; Silva, Marilda Guimaraes; Silva, Clovis Artur; Marie, Suely Kazue Nagahashi
Source: Advances in rheumatology. Unidade: FM
Subjects: MIOSITE, BIÓPSIA, CÉLULAS MUSCULARES, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SHINJO, Samuel Katsuyuki et al. Comparison between treatment naive juvenile and adult dermatomyositis muscle biopsies: difference of inflammatory cells phenotyping. Advances in rheumatology, v. 58, 2018Tradução . . Disponível em: https://doi.org/10.1186/s42358-018-0037-5. Acesso em: 22 ago. 2024.
APA
Shinjo, S. K., Sallum, A. M. E., Shinjo, S. M. O., Silva, M. G., Silva, C. A., & Marie, S. K. N. (2018). Comparison between treatment naive juvenile and adult dermatomyositis muscle biopsies: difference of inflammatory cells phenotyping. Advances in rheumatology, 58. doi:10.1186/s42358-018-0037-5
NLM
Shinjo SK, Sallum AME, Shinjo SMO, Silva MG, Silva CA, Marie SKN. Comparison between treatment naive juvenile and adult dermatomyositis muscle biopsies: difference of inflammatory cells phenotyping [Internet]. Advances in rheumatology. 2018 ; 58[citado 2024 ago. 22 ] Available from: https://doi.org/10.1186/s42358-018-0037-5
Vancouver
Shinjo SK, Sallum AME, Shinjo SMO, Silva MG, Silva CA, Marie SKN. Comparison between treatment naive juvenile and adult dermatomyositis muscle biopsies: difference of inflammatory cells phenotyping [Internet]. Advances in rheumatology. 2018 ; 58[citado 2024 ago. 22 ] Available from: https://doi.org/10.1186/s42358-018-0037-5
Artigo de periodico
Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies (2018)
Souza, Fernando Henrique Carlos de; Miossi, Renata; Moraes, Julio Cesar Bertacini de; Bonfá, Eloísa Silva Dutra de Oliveira; Shinjo, Samuel Katsuyuki
Source: Advances in rheumatology. Unidade: FM
Subjects: MIOSITE, ANTICORPOS MONOCLONAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Fernando Henrique Carlos de et al. Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies. Advances in rheumatology, v. 58, 2018Tradução . . Disponível em: https://doi.org/10.1186/s42358-018-0030-z. Acesso em: 22 ago. 2024.
APA
Souza, F. H. C. de, Miossi, R., Moraes, J. C. B. de, Bonfá, E. S. D. de O., & Shinjo, S. K. (2018). Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies. Advances in rheumatology, 58. doi:10.1186/s42358-018-0030-z
NLM
Souza FHC de, Miossi R, Moraes JCB de, Bonfá ESD de O, Shinjo SK. Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies [Internet]. Advances in rheumatology. 2018 ; 58[citado 2024 ago. 22 ] Available from: https://doi.org/10.1186/s42358-018-0030-z
Vancouver
Souza FHC de, Miossi R, Moraes JCB de, Bonfá ESD de O, Shinjo SK. Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies [Internet]. Advances in rheumatology. 2018 ; 58[citado 2024 ago. 22 ] Available from: https://doi.org/10.1186/s42358-018-0030-z
Artigo de periodico
Hyaluronic acid in dermatomyositis and polymyositis: relationship with disease and cutaneous lesions (2018)
Silva, Marilda Guimaraes; Shinjo, Samuel Katsuyuki
Source: Anais brasileiros de dermatologia. Unidade: FM
Subjects: DOENÇAS AUTOIMUNES, MIOSITE, ADJUVANTES IMUNOLÓGICOS, MANIFESTAÇÕES CUTÂNEAS, GLICOSAMINOGLICANAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Marilda Guimaraes e SHINJO, Samuel Katsuyuki. Hyaluronic acid in dermatomyositis and polymyositis: relationship with disease and cutaneous lesions. Anais brasileiros de dermatologia, v. 93, n. 1, p. 72-75, 2018Tradução . . Disponível em: https://doi.org/10.1590/abd1806-4841.20186727. Acesso em: 22 ago. 2024.
APA
Silva, M. G., & Shinjo, S. K. (2018). Hyaluronic acid in dermatomyositis and polymyositis: relationship with disease and cutaneous lesions. Anais brasileiros de dermatologia, 93( 1), 72-75. doi:10.1590/abd1806-4841.20186727
NLM
Silva MG, Shinjo SK. Hyaluronic acid in dermatomyositis and polymyositis: relationship with disease and cutaneous lesions [Internet]. Anais brasileiros de dermatologia. 2018 ; 93( 1): 72-75.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1590/abd1806-4841.20186727
Vancouver
Silva MG, Shinjo SK. Hyaluronic acid in dermatomyositis and polymyositis: relationship with disease and cutaneous lesions [Internet]. Anais brasileiros de dermatologia. 2018 ; 93( 1): 72-75.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1590/abd1806-4841.20186727
Artigo de periodico
Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity (2017)
Souza, R. C. de; Souza, F. H. C. de; Miossi, R.; Shinjo, Sueli Mieko Oba
Source: Clinical and experimental rheumatology. Unidade: FM
Subjects: MIOSITE, FÁRMACOS IMUNOSSUPRESSORES, EVENTO ADVERSO A MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, R. C. de et al. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity. Clinical and experimental rheumatology, v. 35, n. 6, p. 1011-1013, 2017Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/25488. Acesso em: 22 ago. 2024.
APA
Souza, R. C. de, Souza, F. H. C. de, Miossi, R., & Shinjo, S. M. O. (2017). Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity. Clinical and experimental rheumatology, 35( 6), 1011-1013. Recuperado de http://observatorio.fm.usp.br/handle/OPI/25488
NLM
Souza RC de, Souza FHC de, Miossi R, Shinjo SMO. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity [Internet]. Clinical and experimental rheumatology. 2017 ; 35( 6): 1011-1013.[citado 2024 ago. 22 ] Available from: http://observatorio.fm.usp.br/handle/OPI/25488
Vancouver
Souza RC de, Souza FHC de, Miossi R, Shinjo SMO. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity [Internet]. Clinical and experimental rheumatology. 2017 ; 35( 6): 1011-1013.[citado 2024 ago. 22 ] Available from: http://observatorio.fm.usp.br/handle/OPI/25488

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies